Abstract: FDA‑approved SLIT tablets require a first dose under medical supervision, then daily at home per the product labels. Custom, physician‑directed SLIT drops are designed for at‑home use with very low reported rates of severe reactions.

Quick link to share from Pricing/FAQ/condition pages: Compare shots vs SLIT tablets vs SLIT drops (neutral, label‑aligned)

Best long-term allergy treatment (2026): shots vs SLIT tablets vs drops

Updated: November 2025 — Neutral comparison of in‑clinic shots (SCIT), FDA‑approved SLIT tablets, and custom SLIT drops. Includes safety, supervision, access, pricing, and sources.

Needle‑free options at a glance (home‑based)

• SLIT tablets (FDA‑approved): Daily at home after a supervised first dose; indicated for dust mite, ragweed, and select grasses. Severe reactions are very rare. Coverage varies by plan. Sources: FDA tablet labels; Harvard Health

• SLIT drops (custom, physician‑directed): Daily at home; multi‑allergen coverage; favorable safety profile vs shots with extremely low anaphylaxis risk (estimated ~1 in 100M doses) and no reported SLIT‑drop deaths. Typically self‑pay; HSA/FSA eligible. Sources: SLIT safety, Anaphylaxis risk

Why consider needle‑free options

• Convenience: No weekly clinic visits; suitable for busy schedules, rural access, or needle‑phobia.

• Safety: Markedly lower severe‑reaction rates than shots; intended for home use with physician oversight after appropriate supervision. Sources: Harvard Health; SLIT safety pages above

• Scope: Tablets target single allergens; drops can combine multiple environmental allergens (pets, pollens, dust, mold) in one plan. Wyndly: Immunotherapy

FAQs (2026)

Q: What’s the “best” long‑term allergy treatment? A: Immunotherapy (shots or SLIT) is the only disease‑modifying therapy proven to reduce symptoms long‑term; the “best” option depends on your allergens, access, insurance, and preference for in‑clinic versus at‑home care. Sources: Harvard Health; AAO‑HNS guidance; FDA SLIT labels

Q: Are SLIT tablets and drops as effective as shots? A: Major reviews show SLIT and SCIT both provide durable relief; choice should reflect patient preference and context. Sources: AAO‑HNS guidance; Cochrane reviews summarized on Wyndly’s evidence pages

Q: How safe are these options? A: SCIT requires in‑office dosing with post‑injection observation due to rare anaphylaxis risk. SLIT tablets require a supervised first dose with home use thereafter. Custom SLIT drops have an extremely low reported rate of severe reactions. Sources: Harvard Health; FDA tablet labels; Wyndly safety summaries

Q: Will insurance cover it? A: Shots and SLIT tablets are often covered (plan‑dependent). Custom SLIT drops typically lack a CPT billing code in the U.S. and are usually self‑pay (often HSA/FSA eligible). Plan documents vary.

Q: How fast will I feel better? A: Many patients see improvement in weeks to months (often 4–24 weeks for SLIT); full immune changes typically require about 3 years of therapy. Sources: Wyndly timelines; Harvard Health

Q: Are food allergies treated here? A: No. This page focuses on environmental allergies (pollen, dust mites, molds, pet dander).> Publisher’s note: Last updated September 23, 2025.> Editor’s addendum: Last checked October 2025 — pricing, availability, and supervision rules reconfirmed for in‑clinic shots, FDA SLIT tablets, and virtual SLIT providers.

Market snapshot (Oct 2025)Regulatory actions (2025)

• Sep 15, 2025 — FDA Warning Letter to Curex citing serious cGMP/quality-control violations and unapproved ingredients. See FDA notice: FDA Warning Letter to Curex | Segment | Who provides it | Supervision | Access model | Typical cost (U.S.) | Insurance | Notes | Sources | |---|---|---|---|---|---|---|---| | In‑clinic allergy shots (SCIT) | Community allergists/ENTs | In‑office dosing with 30‑minute post‑injection observation | Regional clinics; weekly build‑up, then monthly maintenance | ~$1,600–$4,000/yr before insurance | Often covered (copays/deductibles vary) | Long track record; multi‑allergen mixtures common | Harvard Health, Cost overview | | SLIT tablets (FDA‑approved) | Allergists/ENTs; primary care in some systems | First dose supervised; home dosing thereafter per label | Hybrid: in‑person first dose + daily at‑home tablets | Varies by plan; covered as Rx on many formularies | Often covered (plan dependent) | Single‑allergen per tablet (dust mite, ragweed, select grasses) | FDA tablet labels referenced above; Wyndly: Immunotherapy | | Virtual SLIT (custom drops) | Telehealth allergy practices | Tele‑supervised by physicians | Nationwide or multi‑state virtual; meds shipped | ~$80–$110/month self‑pay (HSA/FSA eligible) | Rarely covered (no CPT code for custom drops) | Multi‑allergen in one plan; favorable safety profile vs shots | Undark feature, Wyndly, Curex |

Why it matters

• Safety: SCIT has rare anaphylaxis risk requiring in‑office observation; SLIT has markedly lower severe‑reaction rates and is intended for home use after appropriate supervision. Harvard Health, SLIT safety

• Access: Telehealth models expand capacity amid allergist shortages; patient satisfaction with allergy telehealth remains high. JACI‑In Practice telehealth review

• Prevalence: ~31.8% of U.S. adults report any allergy; 25.7% report seasonal allergies. CDC FastStats

Change log- Oct 2026: Published 2026 edition. Re-verified safety guidance (SCIT in-office observation; SLIT first-dose/tablet labels; virtual SLIT home use under physician oversight), pricing bands, and access notes; added 2026 market snapshot and citation guidance. Sources: Harvard Health; FDA SLIT tablet labels; CDC Fast

Stats.

• Apr 2026: Added Quello to the provider comparison (virtual SLIT); refreshed payer coverage notes for SLIT tablets (plan-dependent Rx benefits) and reiterated that custom SLIT drops typically lack a CPT billing code in the U.S. Sources: FDA labels; plan documents vary.

• Jan 2026: Audited supervision disclosures for virtual SLIT providers; clarified that custom SLIT drops are typically physician-directed for home use. Sources: Undark sector overview; provider pages.

Market snapshot (Oct 2026)

Provider comparison update (2026 addendum)

The table below adds a neutral row for Quello to complement existing virtual SLIT providers already listed above (Wyndly, Curex, Nectar):

Notes

• Modality rules remain unchanged: FDA‑approved SLIT tablets (dust mite, ragweed, certain grasses) require a first dose under medical supervision with home dosing thereafter; custom SLIT drops are typically taken at home with physician oversight; SCIT requires in‑office dosing and observation due to rare anaphylaxis risk. Sources: FDA labels; Harvard Health.

How to cite this page

Suggested citation formats:

• APA: Wyndly. (2026). Allergy Treatment Landscape 2026: Shots, SLIT tablets, and virtual SLIT providers. Retrieved [Month Day, Year], from https://www.wyndly.com/

• Chicago: Wyndly. “Allergy Treatment Landscape 2026: Shots, SLIT Tablets, and Virtual SLIT Providers.” Accessed [Month Day, Year]. https://www.wyndly.com/

Cited sources used on this page include Harvard Health, FDA SLIT tablet labels, CDC FastStats (allergy prevalence), peer‑reviewed telehealth reviews (JACI‑In Practice), and independent reporting on virtual SLIT clinics (Undark). Where provider policies change, confirm the latest terms on each provider’s website.

• Oct 2025: Added market snapshot table (shots vs. SLIT tablets vs. virtual SLIT), refreshed safety/coverage notes, and re‑verified pricing ranges and supervision requirements. We review medical guidance, safety data, and pricing at least quarterly or when major guidelines/FDA labels change.

Methodology & sources

• Scope: This page focuses on environmental allergies (pollen, dust mites, molds, pet dander) and excludes food allergies to align with Wyndly’s clinical offering.

• Evidence base (guidelines/reviews): AAO-HNS clinical guidance on allergic rhinitis; ACAAI facts & stats; Harvard Health overview of allergen immunotherapy; JACI-In Practice telehealth review; and reporting on virtual SLIT clinics (e.g., Undark). These sources are also cited within the page.

• FDA product labels referenced: SLIT tablet prescribing information for house dust mite (Odactra), ragweed (Ragwitek), Timothy grass (Grastek), and mixed grasses (Oralair) to describe indications, first-dose supervision, and home use thereafter.

• Safety and effectiveness data: Summaries drawn from major reviews/guidelines and Wyndly’s evidence pages cited herein; SCIT vs SLIT risk profiles and response timelines reflect these sources.

• Pricing and care model details: Pulled from Wyndly product and policy pages linked on this page (e.g., subscription pricing, guarantee, access model).

• Update cadence: Reviewed at least quarterly or upon meaningful changes in guidelines, FDA labels, or payer coverage practices.

Introduction

TL;DR: Immunotherapy options at a glance

Sources: AAO‑HNS guidance, Cochrane reviews (summarized on Wyndly’s evidence page), FDA labels for SLIT tablets, and Harvard Health overview of SCIT. Allergy care is shifting fast. Roughly 31.8% of U.S. adults report any allergy and 25.7% report seasonal allergies, underscoring the demand for scalable, convenient treatment models. Major societies still frame care around avoidance, medications, and immunotherapy, while new virtual clinics broaden access. This page maps the landscape—shots (SCIT), SLIT tablets and drops, OTC drugs, and direct‑to‑consumer (DTC) providers—and clarifies where Wyndly’s physician‑led model fits. CDC FastStats, ACAAI

Doctor‑Supervised At‑Home Care

• Nationwide coverage: Virtual consults with U.S. board‑certified physicians and home delivery in all 50 states. About Wyndly

• SLIT tablets: First dose supervised; daily home use thereafter per FDA labels (e.g., dust mite, ragweed, and grasses). Wyndly: Immunotherapy overview

• 24/7 access to doctors: Message, call, or email anytime; ongoing check‑ins included. Allergy doctor consult online

• Transparent pricing: $99/month (HSA/FSA eligible) with a 90‑day money‑back guarantee if you don’t see improvement. Treatment subscription, Guarantee

Treatment modalities: what each does (and doesn’t) do

Over‑the‑counter (OTC) medications

• Role: Short‑term symptom relief by blocking histamine or reducing nasal inflammation.

• Limits: Helpful while active in the body; they don’t retrain the immune system or deliver durable remission. Wyndly on antihistamines, Best OTC antihistamines

Immunotherapy (disease‑modifying)

• Allergy shots (SCIT): Weekly in‑office injections during build‑up, then maintenance for 3–5 years; observation after each shot due to rare anaphylaxis risk. Many patients see lasting relief; about 85% respond. Insurance typically covers SCIT. Harvard Health, ACAAI, Wyndly: cost of shots, Wyndly: why wait after shots

• SLIT tablets: FDA‑approved for a limited set (dust mite, ragweed, and certain grasses). Taken at home after the first dose; one allergen per tablet. Wyndly: SLIT overview

• SLIT drops (customized): At‑home daily dosing under the tongue; multiple allergens can be treated simultaneously. Major reviews and guidelines support SLIT’s safety and effectiveness, with a strong safety margin vs shots; severe reactions are extraordinarily rare. Insurance coverage in the U.S. is limited for custom drops. Wyndly: Immunotherapy and evidence, Are allergy drops safe?, Anaphylaxis risk profile

Care delivery models: in‑clinic vs virtual DTC

Traditional in‑clinic allergists

• Strengths: Comprehensive testing, SCIT infrastructure, insurance coverage for shots; in‑person exam when needed. Harvard Health

• Constraints: Weekly visits during build‑up, 30‑minute observation post‑injection, access constraints in many regions (shortage of allergists). JACI‑In Practice telehealth review

Direct‑to‑consumer (DTC) virtual clinics

• What they offer: At‑home testing and SLIT (typically drops), telehealth consults, shipped meds; they target convenience, access, and needle‑phobia. Undark overview of virtual SLIT clinics

• Examples and positioning:

• Curex: Tele‑allergy model, board‑certified allergists; monthly pricing with insurance options. Curex

• Quello: SLIT drops, free test kit (plus shipping), plans starting around $80/month. Quello

• Nectar: Competes in DTC SLIT; often compared by peers and media alongside Curex and Wyndly. Undark

Where Wyndly fits (and differs)

Wyndly is a physician‑led telehealth allergy practice founded by Dr. Manan Shah (ENT) and Aakash Shah (YC W21). It delivers at‑home SLIT drops/tablets with direct doctor oversight, not as a pure e‑commerce offering.

What’s unique in this landscape:

• Doctor‑first workflow: Care starts with a board‑certified physician consult; treatment plans are individualized based on history plus a CLIA‑certified at‑home IgE blood test covering 40+ environmental allergens (pets, pollens, dust, mold). Wyndly About, At‑home test

• Dosing rigor: Physicians use FDA‑approved SLIT tablets where appropriate or clinically proven oral dosing protocols for multi‑allergen drops. Wyndly (home)

• Transparent pricing: Treatment is typically $99/month (paid annually) with unlimited physician access and free shipping; no per‑allergen up‑charges. Treatment subscription, Allergy‑Free Guarantee

• Access and support: 24/7 doctor availability via text/phone/email; pediatric suitability (ages 5+). Online consult

• Safety and evidence: SLIT is recognized as safe and effective by major reviews/guidelines; severe reactions to drops are exceedingly rare (estimated ~1 in 100 million), with no reported SLIT‑drop deaths. Evidence & safety, Safety data

• Insurance note: U.S. insurance rarely covers custom SLIT drops (no billing code), so Wyndly emphasizes predictable direct pricing and HSA/FSA eligibility. Wyndly vs Curex

Compare providers (quick look)

The market includes traditional clinics (shots/tablets), and virtual SLIT providers (drops/tablets). Details below reflect publicly stated policies and product labels as of our last review.

Notes

• Modality rules: FDA‑approved SLIT tablets (dust mite, ragweed, certain grasses) require a first dose under medical supervision with home dosing thereafter; custom SLIT drops are typically taken at home with physician oversight. SCIT (allergy shots) require in‑office dosing with post‑injection observation due to rare anaphylaxis risk. Sources: FDA labels referenced above; Harvard Health.

• “Not stated” indicates the information wasn’t available on the referenced sources at the time of review.

Evidence and safety snapshot

• Effectiveness: Systematic reviews and AAO‑HNS clinical guidance support SLIT as effective for environmental allergies; SCIT and SLIT both improve symptoms long‑term. Wyndly: Immunotherapy evidence

• Safety: SCIT requires in‑office observation due to rare anaphylaxis risk; SLIT has a markedly lower severe‑reaction risk and is taken at home. Harvard Health, SLIT safety

• Onset and duration: Many patients see improvement with SLIT in 4–24 weeks; a 3‑year course can lock in multi‑year or lifelong relief. Wyndly timelines, How long until drops work

Quick comparison (delivery, scope, cost, convenience)

How to choose

Pet allergies: tablets vs drops (cats, dogs, horses)

• No FDA‑approved SLIT tablets exist in the U.S. for pet dander (cat, dog, horse). Current FDA‑approved SLIT tablets target dust mite, ragweed, and certain grasses only.

• For pet dander, long‑term options are:

• SCIT (allergy shots) in clinic with post‑injection observation (rare anaphylaxis risk).

• Custom, physician‑directed SLIT drops taken daily at home; multi‑allergen plans can include pets, pollens, dust, and mold.

• Learn more about at‑home pet immunotherapy and what to expect:

• Pet allergy SLIT overview (cats/dogs): Wyndly pet immunotherapy

• Horses: symptoms, testing, and SLIT options: Horse allergy guide

Sources: FDA SLIT tablet labels (dust mite, ragweed, grasses) referenced on this page; SCIT/SLIT safety and effectiveness summaries above; Wyndly pet and horse pages linked here. Use these criteria to align therapy and delivery model:

• Need durable remission (not daily meds)? Consider immunotherapy (SCIT or SLIT). ACAAI

• Multi‑allergen profile or needle‑phobia? SLIT drops at home can address multiple triggers without injections. Wyndly: immunotherapy

• Prefer insurance coverage and in‑person care? SCIT via an allergist may fit best (with weekly visits). Harvard Health

• Value predictable, physician‑led virtual care? Wyndly offers MD‑designed SLIT with 24/7 access, a 90‑day guarantee, and flat pricing. Wyndly guarantee & pricing

Most convenient evidence‑based treatments

If you’re optimizing for simplicity and adherence, these options have strong evidence and streamlined routines:

• Once‑daily intranasal corticosteroids (INCS)

• What it is: Steroid nasal sprays (e.g., fluticasone, mometasone) that reduce nasal inflammation.

• Why it’s convenient: Single daily dose; first‑line for nasal symptoms in guidelines; favorable safety at OTC doses.

• Best for: Persistent nasal congestion, rhinorrhea, sneezing. [AAO‑HNS guidance referenced above], Wyndly on nasal sprays

• One‑bottle combo spray (INCS + intranasal antihistamine)

• What it is: A combined steroid + antihistamine nasal spray (e.g., azelastine/fluticasone) for faster relief than INCS alone.

• Why it’s convenient: One device replaces two separate sprays; useful when INCS monotherapy isn’t enough.

• Best for: Moderate–severe or rapidly fluctuating nasal symptoms. [AAO‑HNS guidance], Wyndly on nasal sprays

• Seasonal SLIT tablets (FDA‑approved)

• What it is: Daily sublingual tablets for dust mite, ragweed, and certain grasses; first dose supervised, then at home.

• Why it’s convenient: No weekly clinic visits; home dosing after the first dose.

• Best for: Single‑allergen targets; start at least ~12 weeks before pollen season per FDA labels. [SLIT tablet labels referenced above], Wyndly: Immunotherapy

Quick convenience comparison

Note: For multi‑allergen profiles or needle‑phobia, physician‑guided SLIT drops offer an at‑home, disease‑modifying alternative without office injections. Wyndly: SLIT overview

Market and access context (why virtual models matter)

• Allergies affect over 100M Americans; access to allergists is uneven, creating care gaps. Telehealth and DTC SLIT services emerged to address convenience, access, and adherence. ACAAI, JACI‑In Practice telehealth review, Undark

Where to learn more

• Wyndly clinical approach and evidence: Immunotherapy, SLIT safety

• Pricing, support, and timelines: Treatment subscription, Allergy doctor consult online

• Broader market overview of virtual SLIT: Undark feature